Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the global infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial. In: Libby P, Bonow RO, Mann DL, Zipes DP, Eds. Coronary blood flow and myocardial ischaemia. From the study we conclude that TIMI risk score (5 or above) is a reliable tool in predicting in- hospital major adverse cardiac events in ST-segment elevation myocardial infarction.Ĭanty JM, 2008. TIMI risk score for STEMI was significantly higher in patients with MACE compared to patients without MACE (16.95, SD 1.78 versus 3.00, SD 1.10 p<0.001) respectively. TIMI risk score for STEMI was significantly higher in patients with MACE compared to without MACE (16.95, SD 1.78 versus 3.00, SD 1.10 p<0.001) respectively.Ĭonclusion: In hospital major adverse cardiac events (MACE) occurred in 19 (38.0%) cases. In hospital major adverse cardiac events (MACE) occurred in 19 (38.0%) cases. The mean TIMI risk score for STEMI 4.50 (SD 2.38). Results: The mean age of patients was 52.64 (SD 11.88) years and majority of the patients were male (84%) with male to female ratio was 5.25:1. Prior myocardial infarction, coronary revascularization procedures either CABG or angioplasty or coronary stenting co-morbidities such as renal failure, heart failure, cardiomyopathy, valvular heart disease and congenital heart disease were excluded. Fifty patients with definite diagnosis of acute STEMI, received streptokinase, aged above 18 years and both sex were included. Methodology: This cross-sectional prospective study was conducted in the Department of Cardiology, Sylhet MAG Osmani Medical College Hospital, Sylhet during the period from July 2017 to June 2018. Objective: To see the correlation of MACE between High and Low TIMI Risk. Significant hospital resources are dedicated to these high risk patients. Of great concern is the risk of cardiac arrest that accounts for the majority of early deaths and other major adverse cardiac events.
Introduction: Patients with ST-segment elevation myocardial infarction (STEMI) have increased risk for death and adverse cardiac events.
0 kommentar(er)
